Husband & Reznek's Imaging in Oncology

Inbunden, Engelska, 2020

5 382 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Beskrivning

This comprehensive reference provides an overview of the general principles of cancer staging, as well as specific discussions of each tumour type across the body, including lymphoma and haematological malignancies. For each tumour, the pattern of disease involvement and disease spread are emphasized, the state-of-the-art imaging features surveyed, and the latest tumour staging and methods to assess treatment response are addressed. Separate sections discuss metastatic disease and the effects of treatment on normal and diseased tissues. The final section of the book highlights emerging functional and molecular imaging techniques to evaluate the different biological hallmarks of cancer.

Produktinformation

Utgivningsdatum:2020-11-02
Mått:216 x 280 x 48 mm
Vikt:2 960 g
Format:Inbunden
Språk:Engelska
Antal sidor:850
Upplaga:4
Förlag:Taylor & Francis Ltd
ISBN:9781138301238

Utforska kategorier

Mer om författaren

Anju Sahdev is the director of research for Clinical Support Services (CSS) and leads the Research Team within the Department of Imaging. Her many research achievements include multiple awards and prizes from a number of international and national organisations for her work involving MRI and endocrine/GU/gynaecological radiology including RSNA, UKRC, ECR and The British Medical Journal. She is also the reporting radiologist on MEDAL, METRO BIBF, METERO, ICON8, PANDA, PISARRO, LOGS, INTERLACE, ARIEL 3 and NEPTUNE. Sarah Vinnicombe is a Clinical Senior Lecturer in Cancer Imaging and Consultant. Radiologist at Ninewells Hospital Medical School, University of Dundee. She was the British Society of Breast Radiologists' Visiting Professor in 2013 and has been elected Fellow of the International Cancer Imaging Society.

Innehållsförteckning

PART I: PRIMARY TUMOUR EVALUATION AND STAGING. Tumours of the oral cavity and pharynx. Paranasal sinus and nasal cavity neoplasms. Laryngeal tumours. Thyroid cancer. Mediastinal tumours. Lung cancer. Pleural tumours. Breast cancer. Oesophageal cancer. Gastric cancer. Primary tumours of the liver and biliary tract. Pancreatic malignancy. Renal cancer. Primary adrenal malignancy. Primary retroperitoneal tumours. Bladder cancer. Prostate cancer. Testicular cancer. Ovarian cancer. Cervical and uterine tumours. Colorectal cancer. Primary bone tumours. Soft tissue sarcomas. Neuroendocrine tumours. PART II: HAEMATOLOGICAL MALIGNANCY AND IMMUNE RELATED MALIGNANCY. Lymphoma. Multiple myeloma. PART III: METASTASES. Brain metastases. Lymph node metastases. Lung and pleural metastases. Bone metastases. Liver and spleen metastases. Adrenal metastases. Peritoneal metastases. PART IV: DISEASE RESPONSE AND TREATMENT. Assessment of response to treatment. Tumour-specific disease response criteria. Immunotherapy response. PART V: EFFECTS ON NORMAL TISSUE AND COMPLICATIONS OF TREATMENTS. Oncological effects on the central nervous system. Effects of treatment on the thorax. Effects of treatment on the abdomen and pelvis. Effects of treatment on bone and bone marrow. PART VI: FUNCTIONAL AND MOLECULAR IMAGING. PET-CT: Principles and clinical applications. Functional imaging and emerging techniques in MRI. Functional imaging and emerging techniques in CT. Non-FDG radionuclide imaging and targeted therapies.